Induction of TRIM22 by IFN-γ involves JAK and PC-PLC/PKC, but not MAPKs and pI3K/Akt/mTOR pathways

Journal of Interferon and Cytokine Research

Volumn 33, Issue 10, 2013, Pages 578-587

  Gao, Bo ^a   Xu, Wei ^b   Wang, Yaxin ^a   Zhong, Linmao ^a   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CIS ACTING ELEMENT; FOCAL ADHESION KINASE 2; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; JANUS KINASE; JANUS KINASE 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLCHOLINE PHOSPHOLIPASE C; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROPRANOLOL; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN TYROSINE KINASE; STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TRIPARTITE MOTIF PROTEIN 22; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STIMULATION; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SERUM RESPONSIVE ELEMENT; SIGNAL TRANSDUCTION;

CELL LINE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION KINASE 2; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; INTERFERON-GAMMA; JANUS KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TOR SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC; TYPE C PHOSPHOLIPASES;

EID: 84885654353     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0170     Document Type: Article

References (50)

1. Barr SD, Smiley JR, Bushman FD. 2008. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog 4(2):e1000007.
2. Bouazzaoui A, Kreutz M, Eisert V, Dinauer N, Heinzelmann A, Hallenberger S, Strayle J, Walker R, Rubsamen-Waigmann H, Andreesen R, von Briesen H. 2006. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology 356(1-2):79-94. (Pubitemid 44750026)
3. Brindley DN, Pilquil C, Sariahmetoglu M, Reue K. 2009. Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases. Biochim Biophys Acta 1791(9):956-961.
4. Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, Margottin-Goguet F, Mothes W, Hazan U, Transy C, Pancino G, Nisole S. 2009. Human TRIM gene expression in response to interferons. PLoS One 4(3):e4894.
5. Chang YE, Laimins LA. 2000. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J Virol 74(9): 4174-4182. (Pubitemid 30214423)
6. Chang YJ, Holtzman MJ, Chen CC. 2002. Interferon-gamma-induced epithelial ICAM-1 expression and monocyte adhesion. Involvement of protein kinase C-dependent c-Src tyrosine kinase activation pathway. J Biol Chem 277(9):7118-7126. (Pubitemid 34953100)
7. Deb DK, Sassano A, Lekmine F, Majchrzak B, Verma A, Kambhampati S, Uddin S, Rahman A, Fish EN, Platanias LC. 2003. Activation of protein kinase C delta by IFN-gamma. J Immunol 171(1):267-273. (Pubitemid 36745297)
8. Ducher L, Croquet F, Gil S, Davy J, Féger J, Bréhier A. 1995. Differential expression of five protein kinase C isoenzymes in FAO and HepG2 hepatoma cell lines compared with normal rat hepatocytes. Biochem Biophys Res Commun 217(2): 546-553. (Pubitemid 26011746)
9. Eldin P, Papon L, Oteiza A, Brocchi E, Lawson TG, Mechti N. 2009. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J Gen Virol 90(Pt 3):536-545.
10. Fang P, Hwa V, Rosenfeld RG. 2006. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway. Exp Cell Res 312(8):1229-1239.
11. Gao B, Duan Z, Xu W, Xiong S. 2009. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 50(2):424-433.
12. Gao B, Wang Y, Xu W, Duan Z, Xiong S. 2010. A 5¢ extended IFN-stimulating response element is crucial for IFN-gammainduced tripartite motif 22 expression via interaction with IFN regulatory factor-1. J Immunol 185(4):2314-2323.
13. Giroux M, Schmidt M, Descoteaux A. 2003. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. J Immunol 171(8):4187-4194. (Pubitemid 37238695)
14. Gongora C, Tissot C, Cerdan C, Mechti N. 2000. The interferoninducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28. J Interferon Cytokine Res 20(11):955-961.
15. Hatakeyama S. 2011. TRIM proteins and cancer. Nat Rev Cancer 11(11):792-804.
16. Hattlmann CJ, Kelly JN, Barr SD. 2012. TRIM22: a diverse and dynamic antiviral protein. Mol Biol Int 2012:153415.
17. Jefferies C, Wynne C, Higgs R. 2011. Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat Rev Immunol 11(9):617-625.
18. Jeong YI, Kim SW, Jung ID, Lee JS, Chang JH, Lee CM, Chun SH, Yoon MS, Kim GT, Ryu SW, Kim JS, Shin YK, Lee WS, Shin HK, Lee JD, Park YM. 2009. Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells. J Biol Chem 284(6):3700-3708.
19. Kajaste-Rudnitski A, Marelli SS, Pultrone C, Pertel T, Uchil PD, Mechti N, Mothes W, Poli G, Luban J, Vicenzi E. 2011. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements. J Virol 85(10):5183-5196.
20. Katsoulidis E, Li Y, Mears H, Platanias LC. 2005. The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J Interferon Cytokine Res 25(12):749-756. (Pubitemid 43068486)
21. Kaur S, Lal L, Sassano A, Majchrzak-Kita B, Srikanth M, Baker DP, Petroulakis E, Hay N, Sonenberg N, Fish EN, Platanias LC. 2007. Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. J Biol Chem 282(3):1757-1768. (Pubitemid 47076718)
22. Kaur S, Uddin S, Platanias LC. 2005. The PI3¢ kinase pathway in interferon signaling. J Interferon Cytokine Res 25(12):780-787. (Pubitemid 43068489)
23. Li N, McLaren JE, Michael DR, Clement M, Fielding CA, Ramji DP. 2010. ERK is integral to the IFN-gamma-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages. J Immunol 185(5):3041-3048.
24. Mo XY, Ma W, Zhang Y, Zhao H, Deng Y, Yuan W, Wang Y, Li Y, Zhu C, Liu M, Wu X. 2007. Microarray analyses of differentially expressed human genes and biological processes in ECV304 cells infected with rubella virus. J Med Virol 79(11): 1783-1791. (Pubitemid 47479897)
25. Newton AC. 2001. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 101(8):2353-2364. (Pubitemid 35373023)
26. Nikodemova M, Watters JJ, Jackson SJ, Yang SK, Duncan ID. 2007. Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC) alpha/betaII. J Biol Chem 282(20): 15208-15216. (Pubitemid 47093379)
27. Nishizuka Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9(7):484-496.
28. Nisole S, Stoye JP, Saib A. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3(10):799-808. (Pubitemid 41518740)
29. Obad S, Brunnstrom H, Vallon-Christersson J, Borg A, Drott K, Gullberg U. 2004. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. Oncogene 23(23):4050-4059. (Pubitemid 38747935)
30. Obad S, Olofsson T, Mechti N, Gullberg U, Drott K. 2007. Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow. Leuk Res 31(7):995-1001. (Pubitemid 46856731)
31. Osaki F, Ikeda Y, Suehiro T, Ota K, Tsuzura S, Arii K, Kumon Y, Hashimoto K. 2004. Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells. Atherosclerosis 176(2):279-287. (Pubitemid 39369517)
32. Ozato K, Shin DM, Chang TH, Morse HR. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 8(11):849-860.
33. Park WS, Jung WK, Park SK, Heo KW, Kang MS, Choi YH, Kim GY, Park SG, Seo SK, Yea SS, Liu KH, Shim EB, Kim DJ, Her M, Choi IW. 2011. Expression of galectin-9 by IFN-gamma stimulated human nasal polyp fibroblasts through MAPK, PI3K, and JAK/STAT signaling pathways. Biochem Biophys Res Commun 411(2):259-264.
34. Pine R, Canova A, Schindler C. 1994. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J 13(1):158-167
35. Platanias LC. 2005. Mechanisms of type-I-and type-II-interferonmediated signalling. Nat Rev Immunol 5(5):375-386.
36. Qing Y, Stark GR. 2004. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 279(40):41679-41685. (Pubitemid 39313613)
37. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, Guffanti A, Minucci S, Pelicci PG, Ballabio A. 2001. The tripartite motif family identifies cell compartments. EMBO J 20(9):2140-2151. (Pubitemid 32410584)
38. Sands WA, Clark JS, Liew FY. 1994. The role of a phosphatidylcholine- specific phospholipase C in the production of diacylglycerol for nitric oxide synthesis in macrophages activated by IFN-gamma and LPS. Biochem Biophys Res Commun 199(2):461-466. (Pubitemid 24181684)
39. Singh R, Gaiha G, Werner L, McKim K, Mlisana K, Luban J, Walker BD, Karim SS, Brass AL, Ndung'U T. 2011. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. J Virol 85(1):208-216.
40. Stark GR. 2007. How cells respond to interferons revisited: from early history to current complexity. Cytokine Growth Factor Rev 18(5-6):419-423. (Pubitemid 47302834)
41. Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, Wieland S, Bukh J, Purcell RH, Schultz PG, Chisari FV. 2002. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 99(24):15669-15674. (Pubitemid 35403989)
42. Takaoka A, Tanaka N, Mitani Y, Miyazaki T, Fujii H, Sato M, Kovarik P, Decker T, Schlessinger J, Taniguchi T. 1999. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling. EMBO J 18(9):2480-2488. (Pubitemid 29228484)
43. Tissot C, Mechti N. 1995. Molecular cloning of a new interferoninduced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 270(25): 14891-14898.
44. Tsai CC, Kai JI, Huang WC, Wang CY, Wang Y, Chen CL, Fang YT, Lin YS, Anderson R, Chen SH, Tsao CW, Lin CF. 2009. Glycogen synthase kinase-3beta facilitates IFN-gammainduced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2. J Immunol 183(2):856-864.
45. van Boxel-Dezaire AH, Stark GR. 2007. Cell type-specific signaling in response to interferon-gamma. Curr Top Microbiol Immunol 316:119-154.
46. Venkatesan BA, Mahimainathan L, Ghosh-Choudhury N, Gorin Y, Bhandari B, Valente AJ, Abboud HE, Choudhury GG. 2006. PI 3 kinase-dependent Akt kinase and PKCepsilon independently regulate interferon-gamma-induced STAT1alpha serine phosphorylation to induce monocyte chemotactic protein-1 expression. Cell Signal 18(4):508-518. (Pubitemid 41790371)
47. Wang Y, Gao B, Xu W, Xiong S. 2011. BRG1 is indispensable for IFN-gamma-induced TRIM22 expression, which is dependent on the recruitment of IRF-1. Biochem Biophys Res Commun 410(3):549-554.
48. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, Chew JL, Lee YL, Kuznetsov VA, Sung WK, Miller LD, Lim B, Liu ET, Yu Q, Ng HH, Ruan Y. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124(1):207-219. (Pubitemid 43069320)
49. Wieland S, Thimme R, Purcell RH, Chisari FV. 2004. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 101(17):6669-6674. (Pubitemid 38586032)
50. Zhang J, Das SC, Kotalik C, Pattnaik AK, Zhang L. 2004. The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes. J Biol Chem 279(44):46335-46342. (Pubitemid 39491629)